Every Form 4 that JAMES HARDIE INDUS CDI (JHIUF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow JHIUF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JHIUF filings page.
James Hardie Industries plc (JHX) reported insider equity transactions by Jonathan Skelly, President of James Hardie NA. On 2026-08-25 he exercised 50,000 employee stock options with an exercise price of $11.23 per share, which had been assumed in connection with the acquisition of The AZEK Company Inc. and were exercisable as of July 1, 2025. He then sold a total of 65,000 ordinary shares in open-market transactions at weighted average prices of approximately $30.45 and $30.46 per share, including 50,000 shares sold through a broker-assisted cashless exercise. Following the derivative transaction, he held 287,721 employee stock options directly.
James Hardie Industries plc (JHX) director Jesse G. Singh reported multiple option exercises and related share sales. On August 21 and 24, 2026, he exercised in total 530,100 employee stock options at an exercise price of $11.23 per share, receiving the same number of ordinary shares. The filing shows aggregate sales of 871,557 ordinary shares at weighted-average prices around $30 per share, including broker-assisted cashless exercises and sales by trusts for which Singh or his spouse serve as trustee or grantor-trustee.
James Hardie Industries plc (JHX) reported an equity compensation grant to CEO and director Aaron M. Erter. On 2026-08-20, he received 60,588 ordinary shares in the form of restricted stock units that vest in three equal annual installments beginning on June 15, 2027, subject to continued service. On the same date he was also granted 75,495 non-qualified stock options with a $25.17 exercise price, expiring on 2036-08-20 and vesting in three equal annual installments beginning on June 15, 2027. Following the RSU grant, he directly held 225,181 ordinary shares.
James Hardie Industries plc (JHX) reported that Chief Legal Officer Timothy Beastrom had equity compensation activity involving ordinary shares. On 2026-08-17, he acquired 4,509 ordinary shares upon the vesting of performance-based equity awards under the company’s long-term incentive plans. On the same date, 1,380 shares were delivered or withheld at $30.43 per share to pay the exercise price or tax liability. These transactions reflect routine equity incentive vesting and related share withholding rather than open-market buying or selling.
James Hardie Industries plc (JHX) reported that CEO and director Aaron M. Erter received an award of 59,972 ordinary shares on August 17, 2026, upon vesting of performance-based equity awards under the company’s long-term incentive plans. On the same date, 25,217 ordinary shares were delivered or withheld at $30.43 per share for payment of exercise price or tax liability, resulting in both an acquisition and a disposition of shares.
James Hardie Industries plc (JHX) reported an insider transaction by Chief Accounting Officer David Lawrence Hill. On 2026-08-17, Hill had 910 ordinary shares disposed of at $30.43 per share as a payment of exercise price or tax liability by delivering or withholding securities, rather than as an open-market sale. After this transaction, Hill directly holds 12,923 ordinary shares of JHX.
James Hardie Industries plc (JHX) reported that Chief Operations Officer Ryan Kilcullen received a grant of 7,327 ordinary shares on August 17, 2026, upon vesting of performance-based equity awards under the company’s long-term incentive plans. On the same date, 2,147 shares were delivered or withheld at $30.43 per share for payment of exercise price or tax liability, leaving resulting share holdings not stated in this report.
Hill David Lawrence reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc reported that Chief Accounting Officer David Lawrence Hill received an award of 3,802 ordinary shares in the form of restricted stock units at $26.30 per share on July 15, 2026. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, subject to continued service. After this grant, Hill directly holds 13,833 ordinary shares.
James Hardie Industries plc reported a Form 4 for Chief Legal Officer Timothy Beastrom showing compensation-related equity grants, not open-market trading. He received 6,952 ordinary shares in the form of restricted stock units that were granted at no cash cost and will vest in three equal annual installments starting on the first anniversary of the grant date, subject to continued service. Following this grant, he directly holds 19,633 ordinary shares. He was also granted non-qualified employee stock options on 8,663 underlying ordinary shares at an exercise price of $25.17 per share, expiring on June 15, 2036, which vest in three equal annual installments beginning one year after the grant date.
James Hardie Industries CFO Lada Ryan reported several equity compensation transactions. On June 15, 2026, she acquired 11,422 ordinary shares as a grant and received non-qualified stock options for 14,232 ordinary shares with an exercise price of $25.17 per share, expiring on June 15, 2036.
On June 16, 2026, she exercised employee stock options to acquire 7,700 ordinary shares at $24.45 per share. In connection with this exercise, 7,495 ordinary shares were withheld by the company to cover the exercise price and tax obligations. Following these transactions, she directly holds 70,014 ordinary shares.
James Hardie Industries plc reported that Chief Operations Officer Ryan Kilcullen received new equity awards as part of his compensation. He was granted 7,945 ordinary shares in the form of restricted stock units, which vest in three equal annual installments starting one year after the grant date, subject to continued service.
He also received non-qualified employee stock options for 9,900 ordinary shares at an exercise price of $25.17 per share, expiring on June 15, 2036, vesting in three equal annual installments on each anniversary of the grant date. Following these awards, his direct holdings total 74,444 ordinary shares.
James Hardie Industries reported that Jonathan Skelly, President of James Hardie North America, received equity awards as part of his fiscal year 2027 long-term incentive compensation.
He acquired 11,422 restricted stock units that vest in three equal annual installments starting one year after the grant date, subject to continued service. Following this RSU award, he holds 324,906 ordinary shares directly.
He was also granted non-qualified stock options for 14,232 ordinary shares at an exercise price of $25.17 per share, expiring on June 15, 2036. These options vest in three equal annual installments beginning on the first anniversary of the grant date, also contingent on continued service.
Singh Jesse G reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc director Jesse G. Singh reported receiving a grant of 1,070 ordinary shares on June 15, 2026, increasing his direct holdings to 117,028 ordinary shares. The filing also reports several indirect holdings by family trusts, with no open-market buys or sells disclosed.
James Hardie Industries plc director Howard C. Heckes reported a share award and updated holdings. On 2026-06-15, he received 1,824 ordinary shares at $0.00 per share as a grant under the issuer's Non-Executive Director Compensation Program. Following this compensation-related acquisition, he directly holds 27,883 ordinary shares.
Separately, the filing reports 2,585 ordinary shares held indirectly by the Howard C Heckes Trust, dated 10/2/2008, for which he serves as trustee. The transactions reflect routine equity compensation and updated reporting of both direct and trust-held positions, with no open-market buying or selling disclosed.
Stein Nigel reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc director Nigel Stein received 1,301 ordinary shares as a grant under the company’s Non-Executive Director Compensation Program. The grant was reported at a price of $0.00 per share, indicating it was an equity award rather than an open-market purchase.
Following this compensation grant, Stein directly holds 41,033 ordinary shares. This filing reflects routine director compensation and does not show any sales or disposals of shares.
Pfeifer John C reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc director John C. Pfeifer received a grant of 1,081 ordinary shares as part of the company’s Non-Executive Director Compensation Program. The award was recorded at a price of $0.00 per share, indicating it is compensation rather than an open-market purchase.
Following this grant, Pfeifer directly holds a total of 5,361 ordinary shares. This filing reflects a routine equity-based compensation award to a non-executive director, increasing his direct ownership stake in the company.
Hendrickson Gary E reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc director Gary E. Hendrickson received a grant of 2,099 ordinary shares on June 15, 2026 at $0.00 per share under the company’s Non-Executive Director Compensation Program. This award increased his direct holdings to 25,174 ordinary shares.
In addition to these directly held shares, family trusts associated with Hendrickson hold 105,000 and 284,147 ordinary shares, where he or his spouse serves as trustee with investment control. The Form 4 reflects routine equity compensation rather than an open-market share purchase or sale.
PETERSON RENEE J reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc director Renee J. Peterson received an equity grant of 1,069 ordinary shares. The award, with a reported price of $0.0000 per share, was issued under the company’s Non-Executive Director Compensation Program. Following this grant, Peterson directly holds 41,862 ordinary shares of James Hardie Industries.
Rowland Suzanne B reported acquisition or exercise transactions in this Form 4 filing.
James Hardie Industries plc director Suzanne B Rowland received an award of 1,076 ordinary shares as compensation. The shares were issued at no cash cost under the company’s Non-Executive Director Compensation Program. Following this grant, Rowland directly holds a total of 16,301 ordinary shares.
James Hardie Industries plc director Suzanne B. Rowland bought additional company stock on the open market. On this date, she purchased 3,000 ordinary shares in an open‑market transaction at a price of $22.91 per share. After this buy, she directly owns 15,225 ordinary shares of James Hardie Industries.